Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Ovarian Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Not applicableLooking for participantsNCT07614620
What this trial is testing

Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer

Who this might be right for
SarcomaGerm Cell Tumor of TestisOvarian Tumor+1 more
Institut Bergonié 70
Early research (Phase 1)Study completedNCT03158935
What this trial is testing

The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

Who this might be right for
Advanced Ovarian CancerMalignant Melanoma
University Health Network, Toronto 8
Not applicableUnknownNCT00436774
What this trial is testing

Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorGastrointestinal Complications+7 more
Children's Cancer and Leukaemia Group 60
Not applicableStudy completedNCT00436189
What this trial is testing

Assess Cancer in Ovarian Tumors With Biomarkers.

Who this might be right for
Ovarian Tumor
Ciphergen Biosystems 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT04686682
What this trial is testing

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Who this might be right for
NSCLCSCLCCRPC+5 more
Jacobio Pharmaceuticals Co., Ltd. 152
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT05162846
What this trial is testing

Michigan Genetic Hereditary Testing (MiGHT)

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+4 more
University of Michigan Rogel Cancer Center 793
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT05500391
What this trial is testing

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Who this might be right for
Stage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal Tumors+11 more
Centre Oscar Lambret 88
Early research (Phase 1)Looking for participantsNCT05227326
What this trial is testing

AOH1996 for the Treatment of Refractory Solid Tumors

Who this might be right for
Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4 more
City of Hope Medical Center 92
Not applicableUnknownNCT03742388
What this trial is testing

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

Who this might be right for
Epithelial Ovarian CancerEpithelial Ovarian Tumor of Borderline MalignancyDriving Mutations+1 more
Lei Li 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631
What this trial is testing

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Ended earlyNCT02417753
What this trial is testing

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Who this might be right for
Ovarian CancerOvarian NeoplasmsAscites+2 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Looking for participantsNCT02429700
What this trial is testing

TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors

Who this might be right for
Ovarian Sex Cord Stromal TumorOvarian NeoplasmsOvarian Cancer
Beihua Kong 132
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00423852
What this trial is testing

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 26
Next Page